Search

Your search keyword '"Klinck, Roscoe"' showing total 171 results
Start Over Author "Klinck, Roscoe"
171 results on '"Klinck, Roscoe"'

1. Data from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figure 1 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

3. Legends to Supplementary Tables and Figures from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 3, page 1 of 4 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 4 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure 6 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure 2 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table S1 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 3, page 2 of 4 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

10. Interactive data link from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 2 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 9 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 3, page 4 of 4 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 7 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 8 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 3, page 3 of 4 from Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Gervais-Bird, Julien, primary, Madden, Richard, primary, Paquet, Éric R., primary, Koh, ChuShin, primary, Venables, Julian P., primary, Prinos, Panagiotis, primary, Jilaveanu-Pelmus, Manuela, primary, Wellinger, Raymund, primary, Rancourt, Claudine, primary, Chabot, Benoit, primary, and Abou Elela, Sherif, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 1 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figures 1-5 from Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, primary, Bramard, Anne, primary, Inkel, Lyna, primary, Dufresne-Martin, Geneviève, primary, Koh, ChuShin, primary, Gervais-Bird, Julien, primary, Lapointe, Elvy, primary, Froehlich, Ulrike, primary, Durand, Mathieu, primary, Gendron, Daniel, primary, Brosseau, Jean-Philippe, primary, Thibault, Philippe, primary, Lucier, Jean-Francois, primary, Tremblay, Karine, primary, Prinos, Panagiotis, primary, Wellinger, Raymund J., primary, Chabot, Benoit, primary, Rancourt, Claudine, primary, and Elela, Sherif Abou, primary

Published
2023
Full Text
View/download PDF

19. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine

Author

Diaz, Zuanel, Aguilar-Mahecha, Adriana, Paquet, Eric R, Basik, Mark, Orain, Michèle, Camlioglu, Errol, Constantin, André, Benlimame, Naciba, Bachvarov, Dimcho, Jannot, Guillaume, Simard, Martin J, Chabot, Benoit, Gologan, Adrian, Klinck, Roscoe, Gagnon-Kugler, Thérèse, Lespérance, Bernard, Samson, Benoit, Kavan, Petr, Alcindor, Thierry, Dalfen, Richard, Lan, Cathy, Chabot, Catherine, Buchanan, Marguerite, Przybytkowski, Ewa, Qureshi, Samia, Rousseau, Caroline, Spatz, Alan, Têtu, Bernard, and Batist, Gerald

Published
2013
Full Text
View/download PDF

23. Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3

Author

Paquet Éric R, Tremblay Pierre-Luc, Gout Stéphanie, Pin Anne-Laure, Houle François, Poirier Andrée, Porquet Nicolas, Klinck Roscoe, Auger François A, and Huot Jacques

Subjects
Death receptor-3, E-selectin, colon cancer, PI3 kinase, splice variant, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Extravasation of circulating cancer cells is a key event of metastatic dissemination that is initiated by the adhesion of cancer cells to endothelial cells. It requires interactions between adhesion receptors on endothelial cells and their counter-receptors on cancer cells. Notably, E-selectin, a major endothelial adhesion receptor, interacts with Death receptor-3 present on metastatic colon carcinoma cells. This interaction confers metastatic properties to colon cancer cells by promoting the adhesion of cancer cells to endothelial cells and triggering the activation of the pro-migratory p38 and pro-survival ERK pathways in the cancer cells. In the present study, we investigated further the mechanisms by which the E-selectin-activated pathways downstream of DR3 confer a survival advantage to colon cancer cells. Methods Cell survival has been ascertained by using the WST-1 assay and by evaluating the activation of the PI3 kinase/NFκB survival axis. Apoptosis has been assayed by determining DNA fragmentation by Hoechst staining and by measuring cleavage of caspases-8 and -3. DR3 isoforms have been identified by PCR. For more precise quantification, targeted PCR reactions were carried out, and the amplified products were analyzed by automated chip-based microcapillary electrophoresis on an Agilent 2100 Bioanalyzer instrument. Results Interaction between DR3-expressing HT29 colon carcinoma cells and E-selectin induces the activation of the PI3K/Akt pathway. Moreover, p65/RelA, the anti-apoptotic subunit of NFκB, is rapidly translocated to the nucleus in response to E-selectin. This translocation is impaired by the PI3K inhibitor LY294002. Furthermore, inhibition of the PI3K/Akt pathway increases the cleavage of caspase 8 in colon cancer cells treated with E-selectin and this effect is still further increased when both ERK and PI3K pathways are concomitantly inhibited. Intriguingly, metastatic colon cancer cell lines such as HT29 and SW620 express higher levels of a splice variant of DR3 that has no trans-membrane domain and no death domain. Conclusion Colon cancer cells acquire an increased capacity to survive via the activation of the PI3K/NFκB pathway following the stimulation of DR3 by E-selectin. Generation of a DR3 splice variant devoid of death domain can further contribute to protect against apoptosis.

Published
2011
Full Text
View/download PDF

24. Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals

Author

Elela Sherif, Klinck Roscoe, Villemaire Jonathan, Garneau Daniel, Carriero Sandra, Gendron Daniel, Damha Masad J, and Chabot Benoit

Subjects
Biotechnology, TP248.13-248.65
Abstract

Abstract Background We previously described the use of tailed oligonucleotides as a means of reprogramming alternative pre-mRNA splicing in vitro and in vivo. The tailed oligonucleotides that were used interfere with splicing because they contain a portion complementary to sequences immediately upstream of the target 5' splice site combined with a non-hybridizing 5' tail carrying binding sites for the hnRNP A1/A2 proteins. In the present study, we have tested the inhibitory activity of RNA oligonucleotides carrying different tail structures. Results We show that an oligonucleotide with a 5' tail containing the human β-globin branch site sequence inhibits the use of the 5' splice site of Bcl-xL, albeit less efficiently than a tail containing binding sites for the hnRNP A1/A2 proteins. A branch site-containing tail positioned at the 3' end of the oligonucleotide also elicited splicing inhibition but not as efficiently as a 5' tail. The interfering activity of a 3' tail was improved by adding a 5' splice site sequence next to the branch site sequence. A 3' tail carrying a Y-shaped branch structure promoted similar splicing interference. The inclusion of branch site or 5' splice site sequences in the Y-shaped 3' tail further improved splicing inhibition. Conclusion Our in vitro results indicate that a variety of tail architectures can be used to elicit splicing interference at low nanomolar concentrations, thereby broadening the scope and the potential impact of this antisense technology.

Published
2006
Full Text
View/download PDF

26. MOESM3 of Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA

Author

Sutherland, Leslie, Thibault, Philippe, Durand, Mathieu, Lapointe, Elvy, Knee, Jose, Beauvais, Ariane, Kalatskaya, Irina, Hunt, Sarah, Loiselle, Julie, Roy, Justin, Tessier, Sarah, Ybazeta, Gustavo, Stein, Lincoln, Kothary, Rashmi, Klinck, Roscoe, and Benoit Chabot

Subjects
sense organs, skin and connective tissue diseases
Abstract

Additional file 3: Table S1. Array-96: List of genes with changes, by cell line.

Published
2017
Full Text
View/download PDF

27. Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA

Author

Sutherland, Leslie C., primary, Thibault, Philippe, additional, Durand, Mathieu, additional, Lapointe, Elvy, additional, Knee, Jose M., additional, Beauvais, Ariane, additional, Kalatskaya, Irina, additional, Hunt, Sarah C., additional, Loiselle, Julie J., additional, Roy, Justin G., additional, Tessier, Sarah J., additional, Ybazeta, Gustavo, additional, Stein, Lincoln, additional, Kothary, Rashmi, additional, Klinck, Roscoe, additional, and Chabot, Benoit, additional

Published
2017
Full Text
View/download PDF

28. PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa

Author

Tanackovic, Goranka, Ransijn, Adriana, Thibault, Philippe, Abou Elela, Sherif, Klinck, Roscoe, Berson, Eliot L., Chabot, Benoit, Rivolta, Carlo, Tanackovic, Goranka, Ransijn, Adriana, Thibault, Philippe, Abou Elela, Sherif, Klinck, Roscoe, Berson, Eliot L., Chabot, Benoit, and Rivolta, Carlo

Abstract

Proteins PRPF31, PRPF3 and PRPF8 (RP-PRPFs) are ubiquitously expressed components of the spliceosome, a macromolecular complex that processes nearly all pre-mRNAs. Although these spliceosomal proteins are conserved in eukaryotes and are essential for survival, heterozygous mutations in human RP-PRPF genes lead to retinitis pigmentosa, a hereditary disease restricted to the eye. Using cells from patients with 10 different mutations, we show that all clinically relevant RP-PRPF defects affect the stoichiometry of spliceosomal small nuclear RNAs (snRNAs), the protein composition of tri-small nuclear ribonucleoproteins and the kinetics of spliceosome assembly. These mutations cause inefficient splicing in vitro and affect constitutive splicing ex-vivo by impairing the removal of at least 9% of endogenously expressed introns. Alternative splicing choices are also affected when RP-PRPF defects are present. Furthermore, we show that the steady-state levels of snRNAs and processed pre-mRNAs are highest in the retina, indicating a particularly elevated splicing activity. Our results suggest a role for PRPFs defects in the etiology of PRPF-linked retinitis pigmentosa, which appears to be a truly systemic splicing disease. Although these mutations cause widespread and important splicing defects, they are likely tolerated by the majority of human tissues but are critical for retinal cell survival

Published
2017

29. Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons

Author

Best, Andrew, James, Katherine, Dalgliesh, Caroline, Hong, Elaine, Kheirolahi-Kouhestani, Mahsa, Curk, Tomaz, Yaobo Xu, Danilenko, Marina, Hussain, Rafiq, Keavney, Bernard, Wipat, Anil, Klinck, Roscoe, Cowell, Ian G., Cheong Lee, Ka, Austin, Caroline A., Venables, Julian P., Chabot, Benoit, Santibanez Koref, Mauro, Tyson-Capper, Alison, and Elliott, David J.

Subjects
Serine-Arginine Splicing Factors, C100, RNA-Binding Proteins, Nerve Tissue Proteins, C500, Exons, C700, Article, Alternative Splicing, Cell Line, Tumor, Checkpoint Kinase 1, MCF-7 Cells, Humans, RNA, Messenger, Protein Kinases
Abstract

Alternative splicing—the production of multiple messenger RNA isoforms from a single gene—is regulated in part by RNA binding proteins. While the RBPs transformer2 alpha (Tra2α) and Tra2β have both been implicated in the regulation of alternative splicing, their relative contributions to this process are not well understood. Here we find simultaneous—but not individual—depletion of Tra2α and Tra2β induces substantial shifts in splicing of endogenous Tra2β target exons, and that both constitutive and alternative target exons are under dual Tra2α–Tra2β control. Target exons are enriched in genes associated with chromosome biology including CHEK1, which encodes a key DNA damage response protein. Dual Tra2 protein depletion reduces expression of full-length CHK1 protein, results in the accumulation of the DNA damage marker γH2AX and decreased cell viability. We conclude Tra2 proteins jointly control constitutive and alternative splicing patterns via paralog compensation to control pathways essential to the maintenance of cell viability., RNA binding proteins are key regulators of alternative splicing. Here, Best et al. show that the human Tra2α and Tra2ß RNA binding proteins jointly contribute to the control of constitutive and alternative splicing events to regulate essential biological processes including the response to DNA damage.

Published
2014

30. Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells

Author

Laroche-Lefebvre, Constance, primary, Yousefi, Mitra, additional, Daudelin, Jean-François, additional, Charpentier, Tania, additional, Tarrab, Esther, additional, Klinck, Roscoe, additional, Lamarre, Alain, additional, Labrecque, Nathalie, additional, Stäger, Simona, additional, and Duplay, Pascale, additional

Published
2016
Full Text
View/download PDF

32. Tumour-promoting role of SOCS1 in colorectal cancer cells

Author

Tobelaim, William S., primary, Beaurivage, Claudia, additional, Champagne, Audrey, additional, Pomerleau, Véronique, additional, Simoneau, Aline, additional, Chababi, Walid, additional, Yeganeh, Mehdi, additional, Thibault, Philippe, additional, Klinck, Roscoe, additional, Carrier, Julie C., additional, Ferbeyre, Gerardo, additional, Ilangumaran, Subburaj, additional, and Saucier, Caroline, additional

Published
2015
Full Text
View/download PDF

35. RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1

Author

Klinck, Roscoe, primary, Fourrier, Angélique, additional, Thibault, Philippe, additional, Toutant, Johanne, additional, Durand, Mathieu, additional, Lapointe, Elvy, additional, Caillet-Boudin, Marie-Laure, additional, Sergeant, Nicolas, additional, Gourdon, Geneviève, additional, Meola, Giovanni, additional, Furling, Denis, additional, Puymirat, Jack, additional, and Chabot, Benoit, additional

Published
2014
Full Text
View/download PDF

37. Tumor microenvironment–associated modifications of alternative splicing

Author

Brosseau, Jean-Philippe, primary, Lucier, Jean-François, additional, Nwilati, Hanad, additional, Thibault, Philippe, additional, Garneau, Daniel, additional, Gendron, Daniel, additional, Durand, Mathieu, additional, Couture, Sonia, additional, Lapointe, Elvy, additional, Prinos, Panagiotis, additional, Klinck, Roscoe, additional, Perreault, Jean-Pierre, additional, Chabot, Benoit, additional, and Abou-Elela, Sherif, additional

Published
2013
Full Text
View/download PDF

38. MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation

Author

Venables, Julian P., primary, Lapasset, Laure, additional, Gadea, Gilles, additional, Fort, Philippe, additional, Klinck, Roscoe, additional, Irimia, Manuel, additional, Vignal, Emmanuel, additional, Thibault, Philippe, additional, Prinos, Panagiotis, additional, Chabot, Benoit, additional, Abou Elela, Sherif, additional, Roux, Pierre, additional, Lemaitre, Jean-Marc, additional, and Tazi, Jamal, additional

Published
2013
Full Text
View/download PDF

39. RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues

Author

Venables, Julian P., primary, Brosseau, Jean-Philippe, additional, Gadea, Gilles, additional, Klinck, Roscoe, additional, Prinos, Panagiotis, additional, Beaulieu, Jean-François, additional, Lapointe, Elvy, additional, Durand, Mathieu, additional, Thibault, Philippe, additional, Tremblay, Karine, additional, Rousset, François, additional, Tazi, Jamal, additional, Abou Elela, Sherif, additional, and Chabot, Benoit, additional

Published
2013
Full Text
View/download PDF

41. Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience

Author

Gagnon-Kugler, Thérèse, primary, Diaz, Zuanel, additional, Rousseau, Caroline, additional, Aguilar-Mahecha, Adriana, additional, Alcindor, Thierry, additional, Aloyz, Raquel, additional, Assouline, Sarit, additional, Basik, Mark, additional, Bachvarov, Dimcho, additional, Bélanger, Luc, additional, Benlimame, Naciba, additional, Camlioglu, Errol, additional, Chabot, Benoit, additional, Christodoulopoulos, Rosa, additional, Constantin, André, additional, Courtemanche, Chantal, additional, Dao, Isabel, additional, Gosselin, Lise, additional, Guillemette, Chantal, additional, Hains, Marie-Christine, additional, Haliotis, Tina, additional, Nielsen, Torsten Holm, additional, Joncas, Marie-Claude, additional, Kavan, Petr, additional, Klinck, Roscoe, additional, Lebel, Michel, additional, Lespérance, Bernard, additional, Mann, Koren, additional, Masson, Jean-Yves, additional, Metrakos, Peter, additional, McNamara, Suzan, additional, Miller, Wilson H., additional, Orain, Michèle, additional, Panasci, Lawrence, additional, Paquet, Eric, additional, Philie, Michel, additional, Qureshi, Samie, additional, Rodrigue, Denis, additional, Salman, Ayat, additional, Simard, Martin, additional, Spatz, Alan, additional, Têtu, Bernard, additional, Tosikyan, Axel, additional, Tsatoumas, Maria, additional, Vuong, Te, additional, and Batist, Gerald, additional

Published
2012
Full Text
View/download PDF

42. Proteins Associated with the Exon Junction Complex Also Control the Alternative Splicing of Apoptotic Regulators

Author

Michelle, Laetitia, primary, Cloutier, Alexandre, additional, Toutant, Johanne, additional, Shkreta, Lulzim, additional, Thibault, Philippe, additional, Durand, Mathieu, additional, Garneau, Daniel, additional, Gendron, Daniel, additional, Lapointe, Elvy, additional, Couture, Sonia, additional, Le Hir, Hervé, additional, Klinck, Roscoe, additional, Elela, Sherif Abou, additional, Prinos, Panagiotis, additional, and Chabot, Benoit, additional

Published
2012
Full Text
View/download PDF

45. Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3

Author

Porquet, Nicolas, primary, Poirier, Andrée, additional, Houle, François, additional, Pin, Anne-Laure, additional, Gout, Stéphanie, additional, Tremblay, Pierre-Luc, additional, Paquet, Éric R, additional, Klinck, Roscoe, additional, Auger, François A, additional, and Huot, Jacques, additional

Published
2011
Full Text
View/download PDF

46. Alternative splicing of SYK regulates mitosis and cell survival

Author

Prinos, Panagiotis, primary, Garneau, Daniel, additional, Lucier, Jean-François, additional, Gendron, Daniel, additional, Couture, Sonia, additional, Boivin, Marianne, additional, Brosseau, Jean-Philippe, additional, Lapointe, Elvy, additional, Thibault, Philippe, additional, Durand, Mathieu, additional, Tremblay, Karine, additional, Gervais-Bird, Julien, additional, Nwilati, Hanad, additional, Klinck, Roscoe, additional, Chabot, Benoit, additional, Perreault, Jean-Pierre, additional, Wellinger, Raymund J, additional, and Elela, Sherif Abou, additional

Published
2011
Full Text
View/download PDF

47. Cancer-associated regulation of alternative splicing

Author

Venables, Julian P, primary, Klinck, Roscoe, additional, Koh, ChuShin, additional, Gervais-Bird, Julien, additional, Bramard, Anne, additional, Inkel, Lyna, additional, Durand, Mathieu, additional, Couture, Sonia, additional, Froehlich, Ulrike, additional, Lapointe, Elvy, additional, Lucier, Jean-François, additional, Thibault, Philippe, additional, Rancourt, Claudine, additional, Tremblay, Karine, additional, Prinos, Panagiotis, additional, Chabot, Benoit, additional, and Elela, Sherif Abou, additional

Published
2009
Full Text
View/download PDF

48. Identification of Alternative Splicing Markers for Breast Cancer

Author

Venables, Julian P., primary, Klinck, Roscoe, additional, Bramard, Anne, additional, Inkel, Lyna, additional, Dufresne-Martin, Geneviève, additional, Koh, ChuShin, additional, Gervais-Bird, Julien, additional, Lapointe, Elvy, additional, Froehlich, Ulrike, additional, Durand, Mathieu, additional, Gendron, Daniel, additional, Brosseau, Jean-Philippe, additional, Thibault, Philippe, additional, Lucier, Jean-Francois, additional, Tremblay, Karine, additional, Prinos, Panagiotis, additional, Wellinger, Raymund J., additional, Chabot, Benoit, additional, Rancourt, Claudine, additional, and Elela, Sherif Abou, additional

Published
2008
Full Text
View/download PDF

49. Multiple and Specific mRNA Processing Targets for the Major Human hnRNP Proteins

Author

Venables, Julian P., primary, Koh, Chu-Shin, additional, Froehlich, Ulrike, additional, Lapointe, Elvy, additional, Couture, Sonia, additional, Inkel, Lyna, additional, Bramard, Anne, additional, Paquet, Éric R., additional, Watier, Valérie, additional, Durand, Mathieu, additional, Lucier, Jean-François, additional, Gervais-Bird, Julien, additional, Tremblay, Karine, additional, Prinos, Panagiotis, additional, Klinck, Roscoe, additional, Elela, Sherif Abou, additional, and Chabot, Benoit, additional

Published
2008
Full Text
View/download PDF

50. Multiple Alternative Splicing Markers for Ovarian Cancer

Author

Klinck, Roscoe, primary, Bramard, Anne, additional, Inkel, Lyna, additional, Dufresne-Martin, Geneviève, additional, Gervais-Bird, Julien, additional, Madden, Richard, additional, Paquet, Éric R., additional, Koh, ChuShin, additional, Venables, Julian P., additional, Prinos, Panagiotis, additional, Jilaveanu-Pelmus, Manuela, additional, Wellinger, Raymund, additional, Rancourt, Claudine, additional, Chabot, Benoit, additional, and Abou Elela, Sherif, additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results